We suggest to use Appili Therapeutics fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Appili Therapeutics is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate data for thirty available fundamental indicators for Appili Therapeutics, which can be compared to its peers. The stock experiences a very speculative upward sentiment. Check odds of Appili Therapeutics to be traded at C$0.0285 in 90 days. Key indicators impacting Appili Therapeutics' financial strength include:
Understanding current and past Appili Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Appili Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Appili Therapeutics' assets may result in an increase in income on the income statement.
Appili Therapeutics competes with Medicenna Therapeutics, and Cardiol Therapeutics. Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada. APPILI THERAPEUTICS is traded on Toronto Stock Exchange in Canada.
Foreign Associate
Canada
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in Appili Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Appili Stock, because this is throwing your money away. Analyzing the key information contained in Appili Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Appili Therapeutics Key Financial Ratios
Appili Therapeutics' financial ratios allow both analysts and investors to convert raw data from Appili Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Appili Therapeutics over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Appili Therapeutics's current stock value. Our valuation model uses many indicators to compare Appili Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Appili Therapeutics competition to find correlations between indicators driving Appili Therapeutics's intrinsic value. More Info.
Appili Therapeutics is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . At this time, Appili Therapeutics' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Appili Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Appili Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.
Appili Therapeutics Systematic Risk
Appili Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Appili Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Appili Therapeutics correlated with the market. If Beta is less than 0 Appili Therapeutics generally moves in the opposite direction as compared to the market. If Appili Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Appili Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Appili Therapeutics is generally in the same direction as the market. If Beta > 1 Appili Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Appili Therapeutics Total Assets Over Time
Today, most investors in Appili Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Appili Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Appili Therapeutics growth as a starting point in their analysis.
Appili Therapeutics March 15, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Appili Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Appili Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Appili Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Appili Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Appili Therapeutics's daily price indicators and compare them against related drivers.
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.